Annual Shareholders Equity
$413.64 M
+$16.37 M+4.12%
December 31, 2024
Summary
- As of March 12, 2025, KURA annual stockholders equity is $413.64 million, with the most recent change of +$16.37 million (+4.12%) on December 31, 2024.
- During the last 3 years, KURA annual shareholders equity has fallen by -$92.97 million (-18.35%).
- KURA annual shareholders equity is now -32.29% below its all-time high of $610.90 million, reached on December 31, 2020.
Performance
KURA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$413.64 M
-$10.13 M-2.39%
December 31, 2024
Summary
- As of March 12, 2025, KURA quarterly stockholders equity is $413.64 million, with the most recent change of -$10.13 million (-2.39%) on December 31, 2024.
- Over the past year, KURA quarterly shareholders equity has increased by +$16.37 million (+4.12%).
- KURA quarterly shareholders equity is now -32.29% below its all-time high of $610.90 million, reached on December 31, 2020.
Performance
KURA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
KURA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.1% | +4.1% |
| 3 y3 years | -18.4% | +4.1% |
| 5 y5 years | +89.1% | +4.1% |
KURA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.4% | +4.1% | -18.4% | +4.7% |
| 5 y | 5-year | -32.3% | +89.1% | -32.3% | +103.6% |
| alltime | all time | -32.3% | >+9999.0% | -32.3% | +994.8% |
Kura Oncology Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $413.64 M(+4.1%) | $413.64 M(-2.4%) |
| Sep 2024 | - | $423.77 M(-9.1%) |
| Jun 2024 | - | $466.07 M(-7.7%) |
| Mar 2024 | - | $505.08 M(+27.1%) |
| Dec 2023 | $397.27 M(-5.5%) | $397.27 M(-7.6%) |
| Sep 2023 | - | $429.94 M(-6.5%) |
| Jun 2023 | - | $459.68 M(+16.3%) |
| Mar 2023 | - | $395.18 M(-6.0%) |
| Dec 2022 | $420.28 M(-17.0%) | $420.28 M(+0.2%) |
| Sep 2022 | - | $419.62 M(-6.6%) |
| Jun 2022 | - | $449.49 M(-5.6%) |
| Mar 2022 | - | $476.25 M(-6.0%) |
| Dec 2021 | $506.61 M(-17.1%) | $506.61 M(-5.1%) |
| Sep 2021 | - | $533.76 M(-4.4%) |
| Jun 2021 | - | $558.55 M(-4.7%) |
| Mar 2021 | - | $585.99 M(-4.1%) |
| Dec 2020 | $610.90 M | $610.90 M(+99.3%) |
| Sep 2020 | - | $306.50 M(-4.9%) |
| Jun 2020 | - | $322.37 M(+58.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $203.20 M(-7.1%) |
| Dec 2019 | $218.78 M(+35.9%) | $218.78 M(-6.3%) |
| Sep 2019 | - | $233.58 M(-5.3%) |
| Jun 2019 | - | $246.58 M(+64.9%) |
| Mar 2019 | - | $149.56 M(-7.1%) |
| Dec 2018 | $160.99 M(+101.6%) | $160.99 M(-7.8%) |
| Sep 2018 | - | $174.61 M(+55.3%) |
| Jun 2018 | - | $112.40 M(-9.9%) |
| Mar 2018 | - | $124.80 M(+56.3%) |
| Dec 2017 | $79.86 M(+40.4%) | $79.86 M(-10.5%) |
| Sep 2017 | - | $89.20 M(+104.4%) |
| Jun 2017 | - | $43.64 M(-13.1%) |
| Mar 2017 | - | $50.24 M(-11.7%) |
| Dec 2016 | $56.88 M(-30.7%) | $56.88 M(-10.7%) |
| Sep 2016 | - | $63.67 M(-9.1%) |
| Jun 2016 | - | $70.04 M(-7.9%) |
| Mar 2016 | - | $76.07 M(-7.4%) |
| Dec 2015 | $82.10 M(-2491.6%) | $82.10 M(+117.3%) |
| Sep 2015 | - | $37.78 M |
| Dec 2014 | -$3.43 M | - |
FAQ
- What is Kura Oncology annual stockholders equity?
- What is the all time high annual shareholders equity for Kura Oncology?
- What is Kura Oncology annual shareholders equity year-on-year change?
- What is Kura Oncology quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Kura Oncology?
- What is Kura Oncology quarterly shareholders equity year-on-year change?
What is Kura Oncology annual stockholders equity?
The current annual shareholders equity of KURA is $413.64 M
What is the all time high annual shareholders equity for Kura Oncology?
Kura Oncology all-time high annual stockholders equity is $610.90 M
What is Kura Oncology annual shareholders equity year-on-year change?
Over the past year, KURA annual stockholders equity has changed by +$16.37 M (+4.12%)
What is Kura Oncology quarterly stockholders equity?
The current quarterly shareholders equity of KURA is $413.64 M
What is the all time high quarterly shareholders equity for Kura Oncology?
Kura Oncology all-time high quarterly stockholders equity is $610.90 M
What is Kura Oncology quarterly shareholders equity year-on-year change?
Over the past year, KURA quarterly stockholders equity has changed by +$16.37 M (+4.12%)